• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Friday, July 12, 2019

    Time

    10:30 AM - 12:00 PM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1.5 Contact Hour(s)

    Target Audience

    Pharmacist, Nurse

    Cost

    $0.00

    • Overview

      Cardiovascular disease (CVD) remains the leading cause of death in the United States. The American Heart Association estimates that 33% of men aged 40 to 59 and nearly 33% of women aged 60 years and older have high triglyceride levels. Most goals for CVD prevention or management involve raising HDL levels while lowering LDL and triglyceride levels to recommended ranges. However, more and more research is showing that triglyceride levels are an independent risk factor for CVD, greatly increasing the chances of heart disease and stroke. This activity will offer pharmacists a greater understanding of the new cholesterol guidelines and review CV outcomes trials to improve management of patients at risk of ASCVD events. 

      Indepth review of ASCVD cardiovascular trials - printed slides maybe useful if using a phone or small screen.




      Handouts

      Slide Document 19133L01_2pp.pdf
      Slide Document 19133L01_6pp.pdf





      Financial Support By

      Amarin Pharma, Inc.
    • Pharmacist

      Have greater clarity on implementing the new 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol
      Describe the spectrum of major recent ASCVD randomized cardiovascular outcomes trials
      Appreciate the difference between omega-3 fatty acids and their formulations to impact ASCVD events, including the negative role of dietary supplements
      Apply evidence-based guidelines, recent randomized clinical trial evidence, and cost implications to therapeutic approaches for managing patients at high risk of cardiovascular events

      Nurse

      Have greater clarity on implementing the new 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol
      Describe the spectrum of major recent ASCVD randomized cardiovascular outcomes trials
      Appreciate the difference between omega-3 fatty acids and their formulations to impact ASCVD events, including the negative role of dietary supplements
      Apply evidence-based guidelines, recent randomized clinical trial evidence, and cost implications to therapeutic approaches for managing patients at high risk of cardiovascular events
    • Repeat Presentation

      This presentation was last given on 7/12/2019 10:30 AM

      Future Airings

      Date Time
      Tuesday, August 6, 2019 10:30 AM View
      Thursday, September 5, 2019 8:00 PM View

    • Activity Type

      Knowledge

      CE Broker

      20-662297

      Universal Activity Number

      Pharmacist 0798-0000-19-133-L01-P

      Nurse 0798-0000-19-133-L01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.